Mann Fung
Professional Experience
1. Private Sector
- President, MaCaFex Consulting, LLC, Flemington, NJ, USA, 2024-Present
- CEO / CMO, Tavotek BioTherapeutics, Inc, Springhouse, NJ, USA & Suzhou, China, 2019-2024
- Venture Partner, Fidelity Eight Roads VC Fund, Boston (MA, USA) & Shanghai (CN), 2017-2019
- Medical Advisor, BioMotiv VC Fund - Cleveland (OH, USA), 2017-2019
- Vice President, Oncology Innovation, Johnson & Johnson Asia-Pacific Innovation Center, Johnson & Johnson Innovation (JJI), Springhouse, NJ, USA & Shanghai, China, 2015-2017
- Vice President / Cross-Functional Development Leader, Janssen Oncology Research & Development, Johnson & Johnson Pharmaceuticals (J&J-PRD), Raritan, NJ, USA, 2005-2015
- Head of Specialty Pharma Clinical Development Executive Director, Johnson & Johnson - McNeil Pharma Division, Fort Washington, PA, USA, 2003-2005
- Medical Director & Head - Oncology / Critical Care, Japan Clinical Research, Eli Lilly Intercontinental Operations, Kobe, Japan, 2001-2003
- Director, Clinical Research & Regulatory Affairs, Eli Lilly Greater China Regional Operation (TW), Taipei, Taiwan, 1999-2001
- Global Clinical Research Physician, Worldwide Pharmacovigilance and Epidemiology, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA, 1996-1999
2. Academic and Governmental Sector
- Visiting / Adjunct Professor at:
- Biomedical Translation Research Center, Academia Sinica, Taipei, Taiwan, 2025-Present
- School of Life Science (Drug Regulatory Affairs and Policy Program), Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, 2025-Present
- School of Public Health (Regulatory Sciences Research Program), University of Macau, Macau, 2025-Present
- Clinical Research Institute, Peking University, Beijing, China, 2016-Present
- School of Biology & Basic Medical Sciences, SuZhou (SooChow) University, SuZhou, China, 2016-2017
- Medical Officer / Team Leader, Center for Drug Evaluation and Research (CDER) Federal Food and Drug Administration (FDA) Rockville, MD, USA, 1993-1996
- Medical Preceptor, CO-STEP Summer Medical Student Program, Federal Health and Human Services (HHS), Rockville, MD, USA, 1994-1995
- Scientific Preceptor, Inter-disciplinary Scientist Rotation Program, Food and Drug Administration (FDA), Rockville, MD, USA, 1994-1995
- Adjunct Clinical Instructor, Department of Internal Medicine, University of Texas School of Medicine at Houston, Houston, TX, USA, 1992-1993
3. Governance & Scientific Advisory
- Scientific Board Member, Board of Scientific Advisors, Virogin Oncolytic Virus, Inc. Vancouver, Canada, 2015-2023
- Scientific Board Member, Board of Scientific Advisors, YiSheng BioPharma, Co., Ltd Beijing and Maryland, CN / US, 2018-2019
- Scientific Board Member, Board of Scientific Advisors, Wuxi-JNJ Wonder Accelerator, Shanghai, China, 2015-2017
4. Clinic and Pharmacy Sector
- Urgent Care Physician, Students’ Health Service, University of Pennsylvania, Philadelphia, PA, USA, 1995–1996
- Urgent Care Physician, Montgomery Medical Group, Rockville, MD, USA, 1994-1995
- Staff Internist, Department of Internal Medicine, Kelsey-Seybold Clinic, Houston, TX, USA, 1992-1993
- Staff Physician (Hospital Affiliation), Department of Internal Medicine, St. Luke’s Episcopal Hospital, Houston, TX, USA, 1992-1993
- Relief Staff Pharmacist, Various retail and hospital pharmacies, Salt Lake City, Utah, USA, 1988-1989
- Clinical Pharmacist, Family Plaza Pharmacy, West Jordan, UT, USA, 1986-1988
Education and Training
- Master of Health Care Management (MHCM), Harvard University, Boston, MA, USA, 2003-2005
- Master of Business Administration (MBA), Graduate School of Business University of Indianapolis Indianapolis, IN, USA, 1997-1999
- Sub-Specialty Medical Training, Department of Radiation Oncology, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia, PA, USA,1995-1996
- FDA Staff College, Center of Drug Evaluation and Research, Rockville, MD, USA, 1993-1995
- Residency, Department of Internal Medicine, Johns Hopkins University School of Medicine Baltimore, MD, USA, 1990-1992
- Internship, Department of Internal Medicine, Johns Hopkins University School of Medicine Baltimore, MD, USA, 1989-1990
- Medical Doctor (Alpha Omega Alpha), School of Medicine, University of Utah, Salt Lake City, UT, USA, 1985-1989
- B.S. in Pharmacy (Magna Cum Laude), School of Pharmacy, University of Utah, Salt Lake City, UT, USA, 1982-1985
Board Certification and Medical Licensure
- Board Certification, Board certified in Internal Medicine (ABIM), 1992
- Board Certification, Diplomat of National Board Medical Examiner (NBME), 1990
- Medical Licensure, State of Indiana, 1996
- Medical Licensure, State of Pennsylvania, 1995
- Medical Licensure, State of Texas, 1992
- Medical Licensure, State of Maryland, 1990
Professional Membership
- American College of Physicians (Fellow), 1991-Present
- American Society of Clinical Oncology (ASCO), 2001-Present
- Sino-American Pharmaceutical Professionals Association (SAPA), 2005- Present
- American Society of Hematology (ASH), 2012-Present
- International Society of PharmacoEpidemiology (ISPE), 1996-1999
- American Academy of Pharmaceutical Physicians (AAPP), 1996-1999
- Drug Information Association (DIA), 1997-1999
- Japan Association of Pharmaceutical Medicine (JAPM), 2001-2003